Literature DB >> 14463369

Incidence of malformations since the introduction of thalidomide.

I M LECK, E L MILLAR.   

Abstract

Entities:  

Keywords:  ABNORMALITIES; HYPNOTICS AND SEDATIVES/toxicology

Mesh：

Substances：

Year:  1962        PMID： 14463369      PMCID： PMC1925495          DOI： 10.1136/bmj.2.5296.16

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  9 in total

1.  [Thalidomide embryopathy. I. Incidence inside and outside Germany].

Authors:  H WEICKER; H HUNGERLAND
Journal:  Dtsch Med Wochenschr       Date:  1962-05-11       Impact factor: 0.628

2.  [Indications of a current increase of hypoplastic and aplastic deformities of the extremities].

Authors:  H R WIEDEMANN
Journal:  Med Welt       Date:  1961-09-16

3.  Thalidomide and congenital abnormalities.

Authors:  A L SPEIRS
Journal:  Lancet       Date:  1962-02-10       Impact factor: 79.321

4.  Congenital thrombocytopenia associated with aplasia of the radius.

Authors:  L R NILSSON; G LUNDHOLM
Journal:  Acta Paediatr       Date:  1960-05       Impact factor: 2.299

5.  Congenital malformations after a two-hour inactivation of nicotinamide in pregnant mice.

Authors:  L PINSKY; F C FRASER
Journal:  Br Med J       Date:  1960-07-16

6.  Comparison of teratogenic chemicals in the rat and chick embryos; an exhibit with additions for publication.

Authors:  M L MURPHY; C P DAGG; D A KARNOFSKY
Journal:  Pediatrics       Date:  1957-04       Impact factor: 7.124

7.  Congenital malformations in inbred strains of mice induced by riboflavin-deficient, galactoflavin-containing diets.

Authors:  H KALTER; J WARKANY
Journal:  J Exp Zool       Date:  1957-12

8.  Multiple congenital abnormalities in the rat resulting from riboflavin deficiency induced by the antimetabolite galactoflavin.

Authors:  M M NELSON; C D BAIRD; H V WRIGHT; H M EVANS
Journal:  J Nutr       Date:  1956-01-10       Impact factor: 4.798

9.  [On the problem of exogenous causes of severe malformations of the extremities].

Authors:  R A PFEIFFER; W KOSENOW
Journal:  Munch Med Wochenschr       Date:  1962-01-12
  9 in total
  16 in total

Review 1.  Drug-induced congenital defects: strategies to reduce the incidence.

Authors:  M De Santis; B Carducci; A F Cavaliere; L De Santis; G Straface; A Caruso
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Recognition of thalidomide defects.

Authors:  R W Smithells; C G Newman
Journal:  J Med Genet       Date:  1992-10       Impact factor: 6.318

3.  Histology and histochemistry of the long bones in micromelia.

Authors:  A T SPENCER
Journal:  Arch Dis Child       Date:  1963-06       Impact factor: 3.791

4.  Thalidomide babies: management of limb defects.

Authors:  L GILLIS
Journal:  Br Med J       Date:  1962-09-08

5.  Safety of Drugs.

Authors: 
Journal:  Br Med J       Date:  1962-07-28

Review 6.  Thalidomide embryopathy: a model for the study of congenital incomitant horizontal strabismus.

Authors:  M T Miller
Journal:  Trans Am Ophthalmol Soc       Date:  1991

7.  The Thalidomide Legacy.

Authors:  R W Smithells
Journal:  Proc R Soc Med       Date:  1965-07

8.  Drug use before and during pregnancy in Serbia.

Authors:  Marina Odalovic; Sandra Vezmar Kovacevic; Katarina Ilic; Ana Sabo; Ljiljana Tasic
Journal:  Int J Clin Pharm       Date:  2012-06-29

9.  Teratogenesis and lymphocyte stimulation.

Authors:  A S Coulson; L J Summers; D R Inman
Journal:  Br Med J       Date:  1969-07-05

10.  [Cytogenetic and clinical studies in thalidomide damaged children with ear malformations].

Authors:  K Ahrens
Journal:  Arch Klin Exp Ohren Nasen Kehlkopfheilkd       Date:  1966
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.